Biodesix (BDSX) Operating Leases (2022 - 2026)

Biodesix (BDSX) has reported Operating Leases for 5 consecutive years, with $23.7 million the latest figure, recorded in Q1 2026.

• Operating Leases for Q1 2026 came in at $23.7 million, down 3.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.7 million (down 3.31% YoY), and the FY2025 annual result was $24.0 million, down 3.18% from the prior year.
• Operating Leases was $23.7 million for Q1 2026 at Biodesix, down from $24.0 million in the prior quarter.
• Over five years, Operating Leases peaked at $25.5 million in Q2 2024 and troughed at $1.2 million in Q1 2022.
• Average Operating Leases over 5 years is $18.5 million, with a median of $24.1 million recorded in 2025.
• Year-over-year, Operating Leases surged 922.85% in 2023 and retreated 5.37% in 2025.
• Over 5 years, Operating Leases stood at $5.3 million in 2022, then surged by 378.93% to $25.2 million in 2023, then declined by 1.33% to $24.8 million in 2024, then declined by 3.18% to $24.0 million in 2025, then declined by 1.54% to $23.7 million in 2026.
• Per Business Quant data, the three most recent Operating Leases figures were $23.7 million in Q1 2026, $24.0 million in Q4 2025, and $24.4 million in Q3 2025.